Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1651 1759
This examiner grants 47% of resolved cases
Lynn Y. Fan is an examiner in Tech Center 1700 and Art Unit 1651. The examiner has 488 resolved cases, providing a data set for analysis. The allowance rate is 47.3 percent, which suggests the environment for applicants. This rate indicates the portion of applications that result in a grant, requiring a strategic approach to prosecution.
The median days to allowance is 1256, which is the timeline for this examiner. This duration is a factor for applicants to consider. However, the interview lift of 49.5 percent is a metric suggesting that interviews are effective. In Art Unit 1651, an interview can change the chances of success compared to cases without one. The 47.3 percent allowance rate makes this lift a factor for practitioners.
With 488 resolved cases in Tech Center 1700, the examiner 1256 days to allowance is a figure. The 49.5 percent interview lift offers a way to address the challenges of Art Unit 1651. Practitioners should consider direct communication to improve their odds of a grant. These metrics provide a view of the prosecution landscape under this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18325470 | DISHWASHING DETERGENT COMPOSITION COMPRISING XYLANASE AND BLOCK CO-POLYMER | Final Rejection | The Procter & Gamble Company |
| 18747769 | COLLAGEN FIBERS AND ARTICLES FORMED THEREFROM | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18199277 | FOOD PRODUCTION SYSTEM, COMPOSITIONS, AND METHODS OF USING THE SAME | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18776731 | Decellularization and Functionalization of Extracellular Matrix Biomaterials | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 17915652 | SUBMERGED FERMENTATION PROCESS | Non-Final OA | Novozymes A/S |
| 17913103 | CLEANING COMPOSITIONS COMPRISING POLYPEPTIDES HAVING FRUCTAN DEGRADING ACTIVITY | Non-Final OA | Novozymes A/S |
| 18278911 | A CLOCK OSCILLATOR FOR BIOCHEMICAL REACTION COMPUTERS | Final Rejection | SOUTH CHINA UNIVERSITY OF TECHNOLOGY |
| 18549476 | TREATMENT OF EYE DISEASES WITH FRUCTOSYL-AMINO ACID OXIDASE | Non-Final OA | Universiteit Gent |
| 18256199 | TREATMENT OF HEMOPHILIA WITH FITUSIRAN | Non-Final OA | Genzyme Corporation |
| 18553044 | Protein Tyrosine Phosphatases as Biomarkers for Hepatocellular Carcinoma and Uses Thereof | Non-Final OA | Université Libre De Bruxelles |
| 18291230 | ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION | Non-Final OA | SHANGHAI BAO PHARMACEUTICALS CO., LTD. |
| 18260079 | RECOMBINANT HUMAN HYALURONIDASE FORMULATION AND APPLICATION THEREOF | Non-Final OA | Shanghai Bao Pharmaceuticals Co., Ltd. |
| 17276507 | COMPOSITIONS AND METHODS FOR TREATING CELLULITE | Final Rejection | ENDO OPERATIONS LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy